[Oxidized lipoproteins and atherogenesis]. 1993

G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
Institut für Medizinische Biochemie, Karl-Franzens-Universität, Graz.

The assumption that the oxidation of lipoproteins plays an eminent role in the development of atherosclerosis is of increasing significance. Our examinations concerned the kinetics of lipid peroxidation of the poly-unsaturated fatty acids in lipoproteins and the existing protection mechanisms by antioxidants, such as vitamin E and carotenoids. Clinical studies proving a correlation of plasma levels and antioxidants, such as vitamin C and E and carotenoids in correlation with cardiovascular disease are cited and discussed. Certain aldehydes originating during lipid peroxidation in LDL modify the protein part of LDL. The consequence of the oxidative modification of LDL is a decreased recognition of LDL by the LDL-receptor and moreover the uptake by macrophages hereby changing to foam cells. Epitopes as developed in oxidatively modified LDL were also shown immunohistochemically in atherosclerotic plaques. Finally a hypothetic scheme is presented how LDL is oxidized in the vessel wall and how it initiates processes resulting in atherosclerosis.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005487 Foam Cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Cell, Foam,Cells, Foam,Foam Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
May 1996, Cardiologia (Rome, Italy),
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
January 1996, Free radical biology & medicine,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
June 2010, Rinsho byori. The Japanese journal of clinical pathology,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
January 1992, Journal of cardiovascular pharmacology,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
January 1996, Annual review of nutrition,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
June 2000, Arteriosclerosis, thrombosis, and vascular biology,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
January 1960, Revista cubana de cardiologia,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
September 1998, Endocrinology and metabolism clinics of North America,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
June 1999, Annals of the New York Academy of Sciences,
G Jürgens, and Q Chen, and G Ledinski, and G Kager, and A Hammer, and H Esterbauer
December 1990, Pathologie-biologie,
Copied contents to your clipboard!